healthŌme and GalenusRx Forge Strategic Partnership to Launch Genomics-Based Personalized Medication Safety Program

Partnership Aims to Reduce Adverse Drug Events by Combining Pharmacogenomic Testing and Precision Medication Consultation to Provide Personalized Medication Support Plans for healthŌme Policyholders.

On March 20, 2024, healthŌme®, Inc., a leading genomics-based, precision health management company serving the life and critical illness industries, and GalenusRx, Inc., the world's most advanced medication safety organization, announced a strategic partnership to elevate individual health outcomes, optimize medication use and improve medication safety. The partnership marks a critical advancement for healthŌme policyholders to access life-changing personalized medicine and proactive health management. Adverse drug events are the fourth leading cause of death in the United States and are a public health problem that is largely preventable. The partnership embodies a shared vision to improve health and medication safety by integrating GalenusRx's extensive precision clinical pharmacy expertise and proprietary medication safety technology with healthŌme's experience in genomics and innovative precision health and disease management programs. The program offers immediate benefits for healthŌme policyholders taking all types of medications to help understand how their body responds to their medication regimen.

Login Or Register To Read Full Story